FCGR3A (Fc fragment of IgG receptor IIIa)

2007-09-01  

Identity

HGNC
LOCATION
1q23.3
LOCUSID
ALIAS
CD16,CD16A,FCG3,FCGR3,FCGRIII,FCR-10,FCRIII,FCRIIIA,IGFR3,IMD20
FUSION GENES

Other Information

Locus ID:

NCBI: 2214
MIM: 146740
HGNC: 3619
Ensembl: ENSG00000203747

Variants:

dbSNP: 2214
ClinVar: 2214
TCGA: ENSG00000203747
COSMIC: FCGR3A

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000203747ENST00000367967P08637
ENSG00000203747ENST00000367969M9MML0
ENSG00000203747ENST00000426740H0Y755
ENSG00000203747ENST00000436743P08637
ENSG00000203747ENST00000442336C9JC71
ENSG00000203747ENST00000443193P08637

Expression (GTEx)

0
50
100
150
200
250

Pathways

PathwaySourceExternal ID
Natural killer cell mediated cytotoxicityKEGGko04650
Systemic lupus erythematosusKEGGko05322
Natural killer cell mediated cytotoxicityKEGGhsa04650
Systemic lupus erythematosusKEGGhsa05322
Fc gamma R-mediated phagocytosisKEGGko04666
Fc gamma R-mediated phagocytosisKEGGhsa04666
LeishmaniasisKEGGko05140
LeishmaniasisKEGGhsa05140
PhagosomeKEGGko04145
PhagosomeKEGGhsa04145
Staphylococcus aureus infectionKEGGko05150
Staphylococcus aureus infectionKEGGhsa05150
Osteoclast differentiationKEGGko04380
Osteoclast differentiationKEGGhsa04380
TuberculosisKEGGko05152
TuberculosisKEGGhsa05152
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellREACTOMER-HSA-198933
Innate Immune SystemREACTOMER-HSA-168249
Fcgamma receptor (FCGR) dependent phagocytosisREACTOMER-HSA-2029480
FCGR activationREACTOMER-HSA-2029481
Regulation of actin dynamics for phagocytic cup formationREACTOMER-HSA-2029482
Role of phospholipids in phagocytosisREACTOMER-HSA-2029485

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA10004adalimumabChemicalClinicalAnnotationassociatedPD24048425, 27044681
PA10040cetuximabChemicalClinicalAnnotationassociatedPD17704420, 23296156, 27897268, 28719596, 30318772
PA164743704antithymocyte globulinChemicalClinicalAnnotationassociated24322002
PA165292659tocilizumabChemicalClinicalAnnotationassociatedPD30457672
PA165817016Kidney TransplantationDiseaseClinicalAnnotationassociated24322002
PA443434Arthritis, RheumatoidDiseaseClinicalAnnotationassociatedPD19005160, 23505228, 25823782, 26167726, 30457672
PA443560Breast NeoplasmsDiseaseClinicalAnnotationassociatedPD18347005, 21109570
PA444841Lymphoma, FollicularDiseaseClinicalAnnotationassociatedPD12975461, 16609067, 19018870
PA444845Lymphoma, Non-HodgkinDiseaseClinicalAnnotationassociatedPD12975461, 16609067, 19018870
PA445062NeoplasmsDiseaseClinicalAnnotationassociatedPD17704420, 23296156, 27897268, 28719596, 30318772
PA445109Neuromyelitis OpticaDiseaseClinicalAnnotationassociatedPD23505228, 26167726, 30457672
PA445451PsoriasisDiseaseClinicalAnnotationassociatedPD24048425, 27044681
PA446304Lymphoma, B-CellDiseaseClinicalAnnotationassociatedPD12975461, 16609067, 19018870
PA446313Lymphoma, Large-Cell, DiffuseDiseaseClinicalAnnotationassociatedPD12975461, 16609067, 19018870
PA449515etanerceptChemicalClinicalAnnotationassociatedPD24048425, 27044681
PA451261rituximabChemicalClinicalAnnotationassociatedPD12975461, 16609067, 19018870, 23505228, 26167726, 30457672
PA451743trastuzumabChemicalClinicalAnnotationassociatedPD18347005, 21109570
PA452639infliximabChemicalClinicalAnnotationassociatedPD19005160, 24048425, 25823782, 27044681

References

Pubmed IDYearTitleCitations
374613392024Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor Stage.0
384223192024Association of NK cell subsets and cytotoxicity with FCGR3A gene polymorphism in functional NK cell deficiency.0
374613392024Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor Stage.0
384223192024Association of NK cell subsets and cytotoxicity with FCGR3A gene polymorphism in functional NK cell deficiency.0
367469352023FcγRIIIA activation-mediated up-regulation of glycolysis alters MDSCs modulation in CD4(+) T cell subsets of Sjögren syndrome.5
369975842023Analysis of FCGR3A-p.176Val variants in women with recurrent pregnancy loss and the association with CD16a expression and anti-HLA antibody status.0
371148842023Association between the functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta-analysis.1
371497142023Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis.0
376693082023Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism.0
367469352023FcγRIIIA activation-mediated up-regulation of glycolysis alters MDSCs modulation in CD4(+) T cell subsets of Sjögren syndrome.5
369975842023Analysis of FCGR3A-p.176Val variants in women with recurrent pregnancy loss and the association with CD16a expression and anti-HLA antibody status.0
371148842023Association between the functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta-analysis.1
371497142023Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis.0
376693082023Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism.0
349328542022FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.1

Citation

Dessen P

FCGR3A (Fc fragment of IgG receptor IIIa)

Atlas Genet Cytogenet Oncol Haematol. 2007-09-01

Online version: http://atlasgeneticsoncology.org/gene/49750/fcgr3a